You are here
NIH's Definition of a Clinical Trial
This page provides information, tools, and resources about the definition of a clinical trial. Correctly identifying whether a study is considered by NIH to be a clinical trial is crucial to how you will:
- Select the right NIH funding opportunity announcement for your research study
- Write the research strategy and human subjects sections of your grant application and contact proposal
- Comply with appropriate policies and regulations, including registration and reporting in ClinicalTrials.gov
In 2016, NIH launched a multi-faceted effort to enhance its stewardship over clinical trials. The goal of this effort is to encourage advances in the design, conduct, and oversight of clinical trials while elevating the entire biomedical research enterprise to a new level of transparency and accountability. The NIH definition of a clinical trial was revised in 2014 in anticipation of these stewardship reforms to ensure a clear and responsive definition of a clinical trial. Learn more about why NIH has made changes to improve clinical trial stewardship.
NIH Definition of a Clinical Trial
A research study in which one or more human subjects are prospectively assignedThe term "prospectively assigned" refers to a pre-defined process (e.g., randomization) specified in an approved protocol that stipulates the assignment of research subjects (individually or in clusters) to one or more arms (e.g., intervention, placebo, or other control) of a clinical trial. to one or more interventionsAn "intervention" is defined as a manipulation of the subject or subject’s environment for the purpose of modifying one or more health-related biomedical or behavioral processes and/or endpoints. Examples include: drugs/small molecules/compounds; biologics; devices; procedures (e.g., surgical techniques); delivery systems (e.g., telemedicine, face-to-face interviews); strategies to change health-related behavior (e.g., diet, cognitive therapy, exercise, development of new habits); treatment strategies; prevention strategies; and, diagnostic strategies. (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. A "health-related biomedical or behavioral outcome" is defined as the pre-specified goal(s) or condition(s) that reflect the effect of one or more interventions on human subjects’ biomedical or behavioral status or quality of life. Examples include: positive or negative changes to physiological or biological parameters (e.g., improvement of lung capacity, gene expression); positive or negative changes to psychological or neurodevelopmental parameters (e.g., mood management intervention for smokers; reading comprehension and /or information retention); positive or negative changes to disease processes; positive or negative changes to health-related behaviors; and, positive or negative changes to quality of life.
Your human subjects study may meet
the NIH definition of a clinical trial.
Important features that distinguish a clinical trial from a clinical study are whether there is prospective assignment of an intervention, a study design that evaluates the effect of the intervention on the participants, and a health-related biomedical or behavioral outcome.
If these features are present, the study is a clinical trial. Our case studies [link] illustrate how to apply these questions.
Note that studies of surveys, questionnaires, user preferences, and studies involving focus groups are not clinical trials. Likewise, studies that involve secondary research with biological specimens or health information are not clinical trials. Finally, educational studies, such as those with outcomes focusing on memorization, or retention and recall of information to assess teaching methods, are not clinical trials.
Resources to Clarify the Definition
The simplified case studies illustrate the differences between clinical trials and clinical studies using the following four questions:
- Does the study involve human participants?
- Are the participants prospectively assigned to an intervention?
- Is the study designed to evaluate the effect of the intervention on the participants?
- Is the effect being evaluated a health-related biomedical or behavioral outcome?
The cases are grouped into studies involving biomedical interventions and studies involving behavioral interventions.
These FAQs further clarify the application of the clinical trial definition.
Print this decision tree for an easy reference for the four questions that identify a clinical trial.
Related Guide Notice
NOT-OD-15-015 Notice of Revised NIH Definition of “Clinical Trial”